NCT04460807: Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer |
|
|
| Terminated | 3 | 23 | Europe | Exemestane, Mestane, Placebo oral tablet | Ente Ospedaliero Ospedali Galliera, Istituto Di Ricerche Farmacologiche Mario Negri, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Federation of Italian Cooperative Oncology Groups | Ovarian Cancer | 04/23 | 04/23 | | |
NCT05299580 / 2019-004760-21: "Dabrafenib and Trametinib in Circulating Free DNA BRAFV600 Mutated Metastatic Melanoma Patients: a Prospective Phase II, Open Label, Multicentre Study - (Bioliquid TAILOR Study - BIOTAILOR)" |
|
|
| Withdrawn | 2 | 35 | Europe | dabrafenib, Trametinib | Fondazione Melanoma Onlus, Novartis Farma S.p.A. | Melanoma | 03/23 | 03/23 | | |
